Shiranee Sriskandan

Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study

Nicola N. Lynskey, Elita Jauneikaite, Ho Kwong Li et al. · The Lancet Infectious Diseases · 2019 · 235 citations · Full text

Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

Rishi K Gupta, Ewen M. Harrison, Antonia Ho et al. · The Lancet Respiratory Medicine · 2021 · 224 citations · Full text

Specific C‐Terminal Cleavage and Inactivation of Interleukin‐8 by Invasive Disease Isolates of <i>Streptococcus pyogenes</i>

Robert J. Edwards, Graham W. Taylor, Melissa Ferguson et al. · The Journal of Infectious Diseases · 2005 · 201 citations · Full text

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

Chloë I. Bloom, Thomas M Drake, Annemarie B Docherty et al. · The Lancet Respiratory Medicine · 2021 · 192 citations · Full text

The IL-8 Protease SpyCEP/ScpC of Group A Streptococcus Promotes Resistance to Neutrophil Killing

Annelies S. Zinkernagel, Anjuli M. Timmer, Morgan A. Pence et al. · Cell Host & Microbe · 2008 · 180 citations · Full text

Inflammation, Medical Microbiology, Virulence Factor +10